ECM
XFOR icon

ExodusPoint Capital Management’s X4 Pharmaceuticals XFOR Stock Holding History

ExodusPoint Capital Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.7K Sell
14,703
-64,369
-81% -$241K ﹤0.01% 1456
2025
Q4 		$316K Buy
+79,072
New +$287K ﹤0.01% 1299
2021
Q3 		– Sell
-1,896
Closed -$370K – 2709
2021
Q2 		$370K Buy
+1,896
New +$477K ﹤0.01% 1610

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

ExodusPoint Capital Management's XFOR Position: Q1 2026 in Review

ExodusPoint Capital Management reduced its X4 Pharmaceuticals (XFOR) stake by 81% in Q1 2026, selling an estimated $241K and leaving 14,703 shares worth $60.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1456.

ExodusPoint Capital Management first reported a position in XFOR in Q2 2021 and has held it in 3 quarters since. The position peaked at $370K in Q2 2021. 84 funds tracked by Wall St. Rank hold XFOR as of Q1 2026.

  • ExodusPoint Capital Management held 14,703 shares of X4 Pharmaceuticals worth $60.7K as of Q1 2026.
  • ExodusPoint Capital Management sold 64,369 X4 Pharmaceuticals shares in Q1 2026, an estimated $241K.
  • X4 Pharmaceuticals made up ﹤0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #1456 holding.
  • ExodusPoint Capital Management first reported a position in X4 Pharmaceuticals in Q2 2021 and has held it in 3 quarters since.
  • ExodusPoint Capital Management's X4 Pharmaceuticals position peaked at $370K in Q2 2021.
  • 84 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.